Fulgent Genetics Inc

Research Fulgent Genetics Inc (FLGT) on Bullrun: market cap USD 583.06M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerFLGT
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryDiagnostics & Research
• CurrencyUSD
• Market capUSD 583.06M
• Financial periodFY2025
• RevenueUSD 322.67M
• Revenue growth13.8%
• Net income-USD 60.51M
• Free cash flow-USD 124.21M
• Gross margin40.6%

Valuation Snapshot

latest market cap is USD 583.06M.

About Fulgent Genetics Inc

Fulgent Genetics, Inc. provides clinical diagnostic and therapeutic development solutions to physicians and patients in the United States and internationally. The company's clinical diagnostic solutions include molecular diagnostic testing; genetic testing; anatomic pathology laboratory tests and testing services, such as gastrointestinal pathology, dermatopathology, urologic pathology, breast pathology, neuropathology, and hematopathology; oncology tests and testing services;

Frequently asked questions

What is Fulgent Genetics Inc's market cap?

Fulgent Genetics Inc's market capitalization is USD 583.06M.

What does Fulgent Genetics Inc do?

Fulgent Genetics, Inc. provides clinical diagnostic and therapeutic development solutions to physicians and patients in the United States and internationally. The company's clinical diagnostic solutions include molecular diagnostic testing; genetic testing;